An Open-Label Extension Study to Evaluate the Safety and Efficacy of BG9924 When Given in Combination With Methotrexate to Subjects With Rheumatoid Arthritis Who Previously Participated in Study 104RA203.
Phase of Trial: Phase II
Latest Information Update: 27 Jan 2016
At a glance
- Drugs Baminercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Biogen
- 17 Jun 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 16 Oct 2008 Actual patient number (72) added as reported by ClinicalTrials.gov.
- 16 Oct 2008 Status changed from recruiting to discontinued as reportede by ClinicalTrials.gov.